HEMSOL-HC Drug Patent Profile
✉ Email this page to a colleague
When do Hemsol-hc patents expire, and when can generic versions of Hemsol-hc launch?
Hemsol-hc is a drug marketed by Able and is included in one NDA.
The generic ingredient in HEMSOL-HC is hydrocortisone acetate. There is one drug master file entry for this compound. Three suppliers are listed for this compound. Additional details are available on the hydrocortisone acetate profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for HEMSOL-HC?
- What are the global sales for HEMSOL-HC?
- What is Average Wholesale Price for HEMSOL-HC?
Summary for HEMSOL-HC
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 90 |
| Patent Applications: | 4,038 |
| DailyMed Link: | HEMSOL-HC at DailyMed |
US Patents and Regulatory Information for HEMSOL-HC
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Able | HEMSOL-HC | hydrocortisone acetate | CREAM;TOPICAL | 081274-001 | Jun 19, 1992 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
